This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Carlyle (CG) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Carlyle (CG) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Unveiling Carlyle (CG) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Carlyle (CG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2023.
Carlyle (CG) Discontinues PE Investments in US Consumer Brands
by Zacks Equity Research
Carlyle's (CG) private equity business US strategy will retreat from US consumer brands to focus on investments in health care, government services, industrials, technology and financial services.
Why Is Carlyle (CG) Up 2.2% Since Last Earnings Report?
by Zacks Equity Research
Carlyle (CG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SEC Adopts Rules to Increase Transparency Among Private Funds
by Nikita Kataruka
Per SEC's new rules to increase transparency, BX, CG, APO and KKR will have to issue quarterly fee and performance reports, and disclose fee structures.
Carlyle (CG) Falls 7.2% Despite Q2 Earnings & Revenue Beat
by Zacks Equity Research
An increase in AUM and declining expenses support Carlyle's (CG) Q2 results. However, lower revenues are concerning.
Carlyle (CG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Carlyle (CG) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Carlyle (CG) Dips 13.5% on Q1 Earnings & Revenue Miss, AUM Rises
by Zacks Equity Research
An increase in AUM supports Carlyle's (CG) Q1 results. However, lower revenues and rising expenses are concerning.
Why Is Carlyle (CG) Down 2.6% Since Last Earnings Report?
by Zacks Equity Research
Carlyle (CG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Carlyle (CG) Q4 Earnings Beat on Lower Expenses, AUM Rises
by Zacks Equity Research
An increase in AUM and declining expenses support Carlyle's (CG) Q4 results. However, lower revenues are a concern.
Is the Options Market Predicting a Spike in Carlyle Group (CG) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carlyle Group (CG) stock based on the movements in the options market lately.
Why Is Carlyle (CG) Up 11.4% Since Last Earnings Report?
by Zacks Equity Research
Carlyle (CG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Options Traders Betting on a Big Move in Carlyle Group (CG) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carlyle Group (CG) stock based on the movements in the options market lately.
Carlyle (CG) Q3 Earnings Beat, Stock Slips on Lower AUM
by Zacks Equity Research
Declines in AUM and revenues on lower realized performance revenues impede Carlyle's (CG) Q3 results. However, lower expenses alleviate the bottom-line pressure.
Truist (TFC) to Buy BankDirect From Texas Capital for $3.4B
by Zacks Equity Research
Truist Financial (TFC) further strengthens its insurance business with a deal to acquire BankDirect for $3.4 billion in cash from Texas Capital (TCBI).
Truist (TFC) Buys Zaloni Assets, Extends Data Management Skills
by Zacks Equity Research
Truist (TFC) acquires key strategic assets from Zaloni. The investment will help TFC deliver better financial experiences and advance its strategy.
Truist Financial (TFC) Agrees to Buy BenefitMall From Carlyle
by Zacks Equity Research
Truist Financial's (TFC) subsidiary, Truist Insurance Holdings, agrees to acquire BenefitMall from funds managed by Carlyle.
Carlyle (CG) Soars 9.5% on Q2 Earnings Beat, Sees Record AUM
by Zacks Equity Research
A rise in revenues on higher fees and assets under management growth support Carlyle's (CG) Q2 results. However, an increase in segmental expenses is a major headwind.
Are Options Traders Betting on a Big Move in Carlyle (CG) Stock?
by Zacks Equity Research
Investors need to pay close attention to Carlyle (CG) stock based on the movements in the options market lately.
Carlyle (CG) to Acquire ManTech for $4.2B in an All-Cash Deal
by Zacks Equity Research
Carlyle (CG) inks an all-cash deal to acquire ManTech for $4.2 billion. The deal can help Carlyle leverage ManTech's sector expertise and resources to accelerate growth and innovation.
Carlyle (CG) Inks Deal to Buy NSM Insurance for $1.775B
by Zacks Equity Research
Carlyle (CG) will leverage NSM Insurance's market-leading specialty insurance distribution platform through the buyout from White Mountains.
Carlyle (CG) Stock Dips on Q1 Earnings & Revenue Miss, AUM Up
by Zacks Equity Research
A rise in revenues on higher fees and assets under management growth support Carlyle's (CG) Q1 results. However, an increase in segment expenses is a major headwind.
Franklin Resources (BEN) Completes Lexington Partners Buyout
by Zacks Equity Research
Franklin (BEN) completes the acquisition of Lexington Partners L.P. in a cash deal of $1.75 billion to boost its alternative asset business.
Carlyle Group (CG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Carlyle Group (CG) closed at $49.42, marking a +1.04% move from the previous day.
Carlyle (CG) Boosts Global Credit Arm With Fortitude Re Deal
by Zacks Equity Research
Carlyle's (CG) new advisory agreement with reinsurer Fortitude Re is set to boost its fee-earnings assets under management by $50 billion.